Ketamine for PTSD: the research, the limits and who it may suit
Small trials found fast relief from PTSD symptoms with ketamine. A larger trial in veterans did not. Here is what the research shows, what guidelines say and who it may suit.
Ketamine has produced fast, real reductions in PTSD symptoms in some small trials, but a larger trial in veterans did not show a clear benefit for PTSD itself, and the 2023 VA/DoD guideline suggests against using it to treat PTSD. It is off-label, it is not first-line, and its clearest role so far is for people whose PTSD comes with depression that has not responded to other treatment. Here is what the research shows and who it might reasonably suit.
The short version
- No form of ketamine is FDA-approved for PTSD. Sertraline and paroxetine are the FDA-approved medications for PTSD.
- A 2021 randomized trial of six IV infusions over two weeks found substantial short-term improvement in chronic PTSD compared with an active placebo.
- A larger 2022 trial in 158 veterans and service members found no significant effect on PTSD symptoms, though the standard dose improved depression.
- The 2023 VA/DoD PTSD guideline gives ketamine a weak recommendation against use for PTSD.
- Trauma-focused psychotherapy remains the strongest treatment. Ketamine, if considered, is usually for PTSD with treatment-resistant depression, after careful screening.
Why ketamine is being studied for PTSD
PTSD involves changes in how the brain processes fear and memory, and chronic stress is associated with loss of connections between nerve cells in regions that regulate emotion. Ketamine acts on the glutamate system, and the leading theory of its antidepressant effect is that it promotes regrowth of some of those connections. Researchers wanted to know whether that might help people with PTSD, particularly those who had not improved with existing treatment.
The need is real. Many people with PTSD do not complete trauma-focused therapy, and the approved medications help some people only partly. A treatment that worked quickly would matter, which is why the results so far deserve a careful reading.
What the trials found
Early single-infusion research
A 2014 study from Mount Sinai published in JAMA Psychiatry gave 41 people with chronic PTSD a single IV infusion of ketamine or midazolam, a sedative used as an active placebo because it also produces noticeable effects. Ketamine reduced PTSD symptoms quickly, within about a day. The effect faded for many participants over the following week or two.
The 2021 repeated-infusion trial
The same group then tested six ketamine infusions over two weeks against six midazolam infusions in 30 adults with chronic PTSD. The results, published in the American Journal of Psychiatry in 2021, showed a substantially larger reduction in PTSD symptoms with ketamine, and 67% of the ketamine group met the study's definition of response compared with a much smaller share of the midazolam group. On average, the response faded within about a month after the infusions ended. It was an encouraging result from a small trial.
The larger veterans trial
A multisite trial sponsored by the Department of Veterans Affairs and published in Neuropsychopharmacology in 2022 randomized 158 veterans and active-duty service members whose PTSD had not responded to antidepressants. They received eight twice-weekly IV infusions of placebo, a low dose of ketamine, or the standard 0.5 mg/kg dose. Neither ketamine dose produced a significant improvement in PTSD symptoms compared with placebo. The standard dose did improve depressive symptoms more than placebo.
That is an important result because it is the largest controlled test so far, and it points to the same conclusion many clinicians had suspected: ketamine's most reliable effect may be on the depression that often comes with PTSD, rather than on PTSD's core symptoms.
Worth knowing
Different trials used different populations, comparators and doses, so they do not cancel each other out. They do show that the evidence is mixed. A 2021 meta-analysis of randomized trials across anxiety-spectrum conditions likewise did not find a clear effect on PTSD, while noting how few studies there were.
What the guidelines say
The 2023 VA/DoD Clinical Practice Guideline for the Management of PTSD and Acute Stress Disorder places ketamine among the medications it suggests against for treating PTSD. That is a weak recommendation against, meaning the panel judged that the evidence did not support using it for PTSD. It is not the same as a finding that ketamine is harmful, and it does not address ketamine for depression.
The same guideline gives its strongest recommendations to trauma-focused psychotherapies, such as prolonged exposure, cognitive processing therapy and EMDR, and recommends sertraline, paroxetine, fluoxetine or venlafaxine where medication is used. NICE guidance in the UK also puts trauma-focused psychological therapy first.
Spravato and PTSD
Spravato (esketamine) is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior. It is not approved for PTSD. If someone with PTSD also has major depression that has failed at least two adequate antidepressant trials, Spravato may be considered for the depression, under the supervised REMS program. Our comparison of Spravato and generic ketamine explains the difference.
Who it may suit
Based on current evidence, ketamine is most reasonably discussed for adults who:
- Have PTSD together with major depression that has not responded to adequate antidepressant trials
- Have tried, or cannot currently access or tolerate, trauma-focused psychotherapy
- Have passed screening for psychosis, bipolar disorder, uncontrolled high blood pressure, heart disease, substance use and pregnancy
- Can attend supervised sessions and continue with therapy and psychiatric follow-up
Even then, an honest clinician will frame ketamine as a possible tool for the depression, with uncertain effects on PTSD itself.
Be careful here
Ketamine causes dissociation, which can feel like the detachment some people experience during flashbacks. For some trauma survivors that is distressing. Substance use problems are also common alongside PTSD, and ketamine can be misused. Both are reasons supervision and careful screening matter more, not less, and reasons at-home ketamine is a poor fit for many people with PTSD. The FDA warned in 2023 about compounded ketamine used at home for psychiatric conditions.
What ketamine does not replace
Trauma-focused therapy works on the memories, beliefs and avoidance that keep PTSD going. Ketamine, at best, may lift mood quickly enough to make that work easier. It does not do the work itself, and no trial has shown it to be a substitute. Sleep is often badly disrupted in PTSD and is worth treating in its own right, as our post on sleep and mental health explains.
Veterans can also contact the Veterans Crisis Line by dialing 988 and pressing 1.
Where to start
If PTSD is affecting your life, the most useful first step is an evaluation that looks at the whole picture: trauma history, depression, sleep, substance use and what you have already tried. Our pillar guide to ketamine for treatment-resistant depression covers screening and the questions to ask any provider, and our ketamine therapy page explains how Aone decides who is a candidate and who is not.
Questions patients ask us
Is ketamine FDA-approved for PTSD?
No. No form of ketamine is FDA-approved for PTSD. The medications approved for PTSD are sertraline and paroxetine. Spravato is approved for specific forms of depression, not PTSD. Ketamine for PTSD is off-label, which is legal, but means there is no approved dose or schedule for it.
What did the 2021 ketamine PTSD trial find?
A Mount Sinai trial published in the American Journal of Psychiatry gave 30 adults with chronic PTSD six infusions of ketamine or midazolam over two weeks. Ketamine produced a substantially larger reduction in PTSD symptoms, and 67 percent of the ketamine group met the response definition. On average, the response faded within about a month.
Why did the veterans trial not find a benefit?
Researchers can only speculate. The 2022 trial included 158 veterans and service members whose PTSD had not responded to antidepressants, a population that is often harder to treat. It used saline as placebo and a different schedule. Ketamine improved depression but not core PTSD symptoms compared with placebo. Larger trials can reveal smaller effects than early studies suggest.
Does the VA offer ketamine for PTSD?
The 2023 VA/DoD guideline suggests against ketamine for treating PTSD itself. Some VA facilities offer esketamine for veterans with treatment-resistant depression, which may include veterans who also have PTSD. Availability varies by location. Veterans should ask their VA mental health team what is offered locally.
What is the first-line treatment for PTSD?
Trauma-focused psychotherapy, such as prolonged exposure, cognitive processing therapy or EMDR, has the strongest evidence and is recommended first by the VA/DoD guideline and NICE. Where medication is used, the VA/DoD guideline recommends sertraline, paroxetine, fluoxetine or venlafaxine. Ketamine is not among the recommended options for PTSD.
Can ketamine trigger flashbacks or trauma memories?
It can bring up memories and emotions, and the dissociation ketamine causes may feel similar to the detachment some trauma survivors experience. For some people this is distressing. A supervised setting, a clinician who understands trauma and a clear plan for what to do if a session gets difficult all matter for people with PTSD.
Is ketamine-assisted psychotherapy different from ketamine infusions?
Yes. Ketamine-assisted psychotherapy combines dosing with therapy sessions before, during or after, while some infusion clinics provide dosing with little or no therapy. The idea is that ketamine may make therapeutic work easier. Controlled evidence for this combined approach in PTSD is still limited, and programs vary widely in quality.
Is ketamine safe for someone with PTSD and substance use?
It needs careful evaluation. Ketamine can be misused, and substance use problems often occur alongside PTSD. A history of substance use is not always an absolute bar, but it raises the risk and generally rules out at-home dosing. Treating the substance use directly is usually part of the plan.
Will ketamine help PTSD nightmares and sleep?
There is little evidence that ketamine specifically improves PTSD nightmares. Sleep problems in PTSD are common and treatable in their own right, with approaches like CBT for insomnia and imagery rehearsal therapy for nightmares. Discuss sleep directly with your clinician rather than expecting ketamine to address it.
Who might reasonably consider ketamine with PTSD?
Mainly adults whose PTSD comes with major depression that has not responded to adequate antidepressant trials, who have tried or cannot access trauma-focused therapy, who pass screening for psychosis, bipolar disorder, heart risks, substance use and pregnancy, and who can attend supervised sessions with ongoing care. Even then, effects on PTSD itself are uncertain.
Talk to a licensed clinician
Reading about a treatment is not the same as knowing whether it fits your history. A consultation is a conversation about your own situation — not a sales call, and not a promise of any outcome.
